Community-Acquired Pneumonia Treatment Guidelines

Introduction to Recommended Regimens

• The Infectious Diseases Society of America (IDSA) and the American Thoracic Society (ATS) recommend against using ciprofloxacin or cefuroxime as first-line monotherapy for hospitalized patients with community-acquired pneumonia, instead suggesting either a respiratory fluoroquinolone (levofloxacin or moxifloxacin) as monotherapy, or a β-lactam (ceftriaxone, cefotaxime, or ampicillin) plus a macrolide 1, 2.

Limitations of Ciprofloxacin and Cefuroxime

• Ciprofloxacin lacks adequate activity against Streptococcus pneumoniae, a common pathogen in community-acquired pneumonia, accounting for two-thirds of bacteremic pneumonia cases 3, 4.
• Cefuroxime is not listed among preferred β-lactams for hospitalized community-acquired pneumonia patients due to its less reliable coverage against drug-resistant S. pneumoniae 1, 2, 4.

Recommended Treatment Regimens

• The IDSA/ATS guidelines recommend respiratory fluoroquinolone monotherapy (levofloxacin 750mg IV daily or moxifloxacin 400mg IV daily) as a strong option (Level I evidence) for hospitalized non-ICU patients 1, 2.
• Another recommended regimen is a β-lactam plus macrolide combination, such as ceftriaxone 1g IV every 24 hours plus azithromycin or clarithromycin, also a strong option (Level I evidence) 1, 2.

Clinical Decision Algorithm

• Patients with severe structural lung disease, recent hospitalization, or recent antibiotic use should be assessed for Pseudomonas risk factors, requiring ICU-level coverage 6.
• For patients without Pseudomonas risk, assessment for penicillin allergy is necessary; if present, respiratory fluoroquinolone monotherapy is recommended 1, 2.

Switching to Oral Therapy

• Patients can be switched from IV to oral therapy when they are hemodynamically stable, clinically improving, and able to ingest medications, based on strong recommendation and Level II evidence 1, 2.
• Most patients show clinical response within 3-5 days, at which point switching to oral antibiotics like amoxicillin or levofloxacin can be considered 3, 4, 5.